Celero Ventures Opens $25 Million Early-Stage Fund to Investors Backing the Next Generation of European Software Companies
1.7.2025 10:30:00 EEST | Business Wire | Press release
Celero Ventures, a new venture capital firm founded by experienced software operators Dave Wyatt and Nick Cochran, is now raising its debut $25 million fund to invest in early-stage startups across the UK and Europe. The fund, which is already 25% subscribed, targets pre-seed and seed-stage companies building next-generation AI and data infrastructure.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250701820933/en/
Nick Cochran and David Wyatt (right) Founders of Celero Ventures
Based in London, Celero Ventures is inviting limited partners (LPs) to join its mission of backing exceptional technical founders and accelerating their path to product-market fit and scalable growth.
Wyatt and Cochran bring a rare combination of deep go-to-market (GTM) experience and startup leadership. Together, they helped scale both MuleSoft and Databricks—two of the most successful enterprise software companies of the past decade. Their experience building and leading commercial teams across Europe and North America forms the foundation of Celero’s operator-first investment approach.
“Our goal is to give founders what we wish we’d had earlier in our careers: practical, experienced support from people who’ve built and scaled GTM from the ground up,” said Wyatt. “We’re raising this fund to support those teams early—when execution, speed, and strategic clarity matter most.”
The fund will invest in 20 to 25 companies, primarily across the UK and Europe, with an emphasis on AI, data tooling, and infrastructure software. Celero has already made its first investments, including leading a pre-seed round in a technical founding team building novel AI infrastructure.
Wyatt and Cochran have personally anchored the fund, reinforcing long-term alignment with both founders and investors.
“We’re not just investing capital—we’re investing capability,” said Cochran. “We work side by side with founders on segmentation, hiring, pricing, and repeatable growth playbooks—the kinds of things we’ve done at scale ourselves.”
One of Celero’s early portfolio companies, Catio, is already seeing that approach in action.
“Dave and Nick helped us get our GTM engine humming,” said Boris Bogatin, CEO of Catio. “They bring sharp insight, hands-on support, and a real sense of partnership. They’re the kind of investors you want when things are moving fast and stakes are high.”
Celero’s strategy is grounded in the belief that strong commercial execution is often the difference-maker in early-stage success—especially for technical founding teams. The fund is designed to close that gap by offering both capital and highly relevant operational support.
While the firm is headquartered in London, Celero is building a geographically diverse portfolio across Europe. Its focus is on founders building the infrastructure and applications that will define the AI-native enterprise stack.
Howard Dawber, Deputy Mayor of Business & Growth, said: “It’s great to see London reinforcing its position once more as a global leader in Tech, with London-based Celero Ventures expanding its investment in start-ups across the UK and Europe. This investment will be a game-changer for start-ups in their early stages, offering both funding and operational support at a critical time. Europe is home to incredible talent in the AI and data infrastructure space, and I look forward to seeing how Celero’s backing transforms companies beginning to make their mark in this industry.”
“Europe is home to world-class technical talent,” said Wyatt. “What many of those teams need is sharper, earlier GTM support. That’s what we’re bringing—and we’re looking for LPs who believe in the same opportunity.”
Janet Coyle CBE, Managing Director of Grow London at London & Partners said: "Here in the capital, investors and founders alike benefit from a unique blend of world‑leading talent, unrivalled market access and a quality of life that simply can’t be matched. From the energy of our tech communities to the global networks that span the City and Canary Wharf, London offers VCs and funds a gateway to Europe and beyond. It’s no surprise that more and more investors are calling London home. We look forward to working with Celero Ventures as they back the next generation of AI and infrastructure innovators right here in London.”
Celero Ventures is currently speaking with family offices, high-net-worth individuals, and institutional investors interested in partnering on the next wave of software innovation—alongside a team with deep operating experience and proven track records.
For more information on participating in the fund, visit celeroventures.com or contact the team directly.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250701820933/en/
Contacts
David Wyatt - David@celeroventures.com - +44 7979 542753
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Textron Aviation Marks 500th Cessna Citation Latitude Rollout22.9.2026 17:19:00 EEST | Press release
Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced the rollout of the 500th Cessna Citation Latitude business jet from the company’s Wichita, Kansas, manufacturing facility. The production milestone highlights the continued success of the world’s best-selling midsize business jet and recognizes the employees whose craftsmanship and dedication have helped make the Citation Latitude the trusted choice for operators around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922867287/en/ Textron Aviation marks 500th Cessna Citation Latitude rollout. (Photo Credit: Textron Aviation) “The rollout of the 500th Citation Latitude is a testament to the employees who build this aircraft with dedication and pride every day,” said Eric Cardinali, senior vice president, Manufacturing. “Behind every aircraft is a team committed to delivering the quality and craftsmanship our customers expect. This milestone
OCP Announces Date of Second Quarter and First Half 2026 Earnings22.9.2026 17:00:00 EEST | Press release
OCP S.A. (“OCP” or the “Company”), a global leader in the fertilizer industry, will release its second quarter and first half 2026 results on Tuesday, September 29, 2026. The results will be available to holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers on the OCP Intralinks portal from 10:00 a.m. EDT, 2:00 p.m. Morocco (GMT) and 3:00 p.m. London time (GMT+1). OCP senior management will host a conference call to discuss second quarter and first half 2026 results at 11:00 a.m. EDT, 3:00 p.m. Morocco (GMT) and 4:00 p.m. London time (GMT+1) on Tuesday, September 29, 2026, for holders of the Company’s bonds, qualified institutional buyers, securities analysts and market makers. Eligible parties that have not already registered for access to the Intralinks portal may do so by contacting the Investor Relations Department by emailing g.laraki@ocpgroup.ma. About OCP OCP is a global leader in the fertilizer industry, backed by almost a century
Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 202622.9.2026 16:30:00 EEST | Press release
Takeda(TSE:4502/NYSE:TAK)announced that new data from its oncology pipeline and portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, 2026, in Madrid, Spain. Key data will include a late-breaking abstract on arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343*) and two presentations on TAK-928 (Innovent R&D code: IBI363*). Clinical and real-world analyses of ALUNBRIG® (brigatinib) and FRUZAQLA® (fruquintinib) will also be shared at the congress. “Takeda’s data at ESMO reflect our commitment to delivering rapid progress for patients living with some of the most prevalent and challenging cancers, including advanced gastric cancer and immunotherapy-resistant and previously untreated non-small cell lung cancer,” said Phuong Khanh (P.K.) Morrow, M.D., Head of the Oncology Therapeutic Area Unit at Takeda. “Our mission is to advance new therapeutic approaches for patients who need more options or who remain underserved by cur
Quaise Energy Selected for Up to $25 Million in U.S. Department of Energy Support to Advance World's First Commercial Superhot Geothermal Power Plant22.9.2026 16:30:00 EEST | Press release
Quaise Energy, a leading developer of utility-scale superhot geothermal energy, today announced that it has been selected by the U.S. Department of Energy (DOE) for up to $25 million in funding under the Next-Generation Geothermal Field Tests and Geothermal Resource Characterization and Confirmation funding opportunity. The support brings the U.S. closer to commercializing superhot Enhanced Geothermal Systems — technology that could unlock firm, clean power from hot rock beneath virtually any geography in the country. The funding will advance Project Obsidian, the world's first commercial superhot geothermal power plant, in Central Oregon. It will support analysis of the drilling, stimulation, and flow results of the first two wells to optimize a third well at the Obsidian site. The three-well configuration is targeting average reservoir temperatures of over 300°C and is designed to demonstrate more than 25 megawatts of gross electric power capacity. The DOE funding will also enable Qu
From CSR to Public Health Impact: How Colgate Bright Smiles, Bright Futures® is Driving Behavior Change for the Next Billion Children and Their Families22.9.2026 16:00:00 EEST | Press release
Colgate-Palmolive, the worldwide leader in oral care, announced a strategic evolution in its flagship oral health education program, Colgate Bright Smiles, Bright Futures® (BSBF), reflecting the Company’s commitment to global public health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922129016/en/ Launched in 1991, the program has reached over two billion children and their families across more than 100 countries, demonstrating how private-sector commitment designed to support communities, can become a powerful force for public health, driving healthier behaviors and positive outcomes at scale. From health education curriculum and school programming to mobile dental vans and free oral health screenings, BSBF helps children and their families access care, adopt healthier habits, and improve long-term oral health outcomes. “At Colgate-Palmolive, we believe oral health and healthier, brighter futures are inextricably link
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom